GHRP-2 Acetate: 10mg x10 Vials

GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide studied in Australian preclinical research as an agonist at the growth hormone secretagogue receptor (GHS-R1a). Laboratories investigate GHRP-2 for its growth hormone release profile, appetite-regulating signalling, and downstream IGF-1 pathway effects in controlled endocrine research models.

GHRP-2 and GHRP-6 are both GHS-R1a agonists but are distinct peptides studied for different release profiles. GHRP-2 is often investigated for a more moderate growth hormone response, while GHRP-6 is studied for its strong appetite-stimulation pathways. Their molecular sequences differ, so research parameters: dose, timing, and endpoints: should be designed for the specific peptide under investigation.

No. GHRP-2 Acetate is strictly for laboratory research only. It is not intended for human consumption, performance enhancement, therapeutic application, or diagnostic use. Australian purchasers must confirm legitimate research intent.

Availability varies by product and batch. Where independent testing is complete, batch-specific Certificates of Analysis are available on request. All documentation sources are clearly labelled.

GHRP-2 is dispatched within 1–3 business days from our international fulfilment partners in discrete, temperature-protected packaging. Estimated delivery is 5–9 days from order, processing included, express with a carrier tracking number Australia-wide. Free over $700 AUD. Every order ships express with a carrier tracking number emailed on dispatch. Trial vials are faster: they ship from domestic stock via Australia Post Express, same-day dispatch before 3 PM AEST, arriving in 2–3 business days.